CoChat

Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life

Open access
Turk, Nicole, Ramanujan, Suruchi, Shamloo, Termeh, Craig, Colleen, McLaughlin, Tracey · 2025 · Journal of the Endocrine Society

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Context: Postbariatric hypoglycemia (PBH), complicating up to one-third of bariatric surgeries, is characterized by repeated episodes of severe hypoglycemia and hypoglycemia unawareness that threaten patient safety and impair quality of life. Objective: We tested the hypothesis that use of a continuous glucose monitor (CGM) would reduce hypoglycemia and improve quality of life in patients with PBH. Design: In a crossover design, 14 patients with diagnosed PBH were assigned in random order to sequential treatment with unblinded CGM or blinded CGM/no alarms for 10 days each. Glucose and quality of life measures were compared between the 2 periods. Setting: Outpatient. Outcomes: Hypoglycemia measured by fingerstick blood glucose in response to symptoms or CGM alarm and CGM glucose values; quality of life measures included dietary liberalization and hypoglycemia-related worries/behaviors captured by the Hypoglycemia Fear Survey-II. Results: Baseline frequency of hypoglycemic events, disability, and hypoglycemia-related worries were high. Symptom-triggered hypoglycemic events confirmed by fingerstick glucose were reduced 6-fold (P = .008) and the glucose nadir measured by CGM was >8 mg/dL higher (P = .005) during unblinded use of CGM compared to the blinded comparison period. Hypoglycemia Fear Survey-II scores improved significantly in response to unblinded CGM use compared to the blinded control period (P = .026). The intake of carbohydrate-containing meals increased without increasing rate of postprandial hyper- or hypoglycemia. Conclusion: Use of unblinded CGM in patients with PBH reduces frequency and severity of hypoglycemia and improves quality of life by decreasing hypoglycemia-related worries and enabling a less restrictive diet. CGM should be considered a first-line treatment for patients with PBH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jendso/bvaf106

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Study design overview. Participants were first screened, randomized, and trained in CGM use. Subjects were then assigned to begin with either a 10-day unblinded CGM (Dexcom G6) or 10-day blinded CGM (Dexcom G6 Pro) period. Each monitoring phase was followed by completion of the Hypoglycemia Fear Survey-II (HFS-II), an event diary, and training (if applicable) with a new CGM device. All participants crossed over to the alternate CGM modality for another 10-day period. The study concluded with repeated HFS-II assessments, event diary entries, and CGM data download. Blinded CGM data (Dexcom G6 Pro) was used for all outcome analyses to ensure consistency.
Figure 1. Study design overview. Participants were first screened, randomized, and trained in CGM use. Subjects were then assigned to begin with either a 10-day unblinded CGM (Dexcom G6) or 10-day blinded CGM (Dexcom G6 Pro) period. Each monitoring phase was followed by completion of the Hypoglycemia Fear Survey-II (HFS-II), an event diary, and training (if applicable) with a new CGM device. All participants crossed over to the alternate CGM modality for another 10-day period. The study concluded with repeated HFS-II assessments, event diary entries, and CGM data download. Blinded CGM data (Dexcom G6 Pro) was used for all outcome analyses to ensure consistency.CC BY-NC-ND · PubMed Central
Figure 2. Dietary liberalization defined by frequency of glucose spikes (n = 14). The total number of glucose spikes was significantly higher during the unblinded continuous glucose monitoring (CGM) period compared to the blinded period (P = .005), suggesting potential dietary liberalization when patients were aware of their glucose readings in real time. Each dot represents an individual participant. A glucose spike was defined as an increase in CGM glucose of ≥40 mg/dL above baseline within 1 hour, which resolved when glucose returned to baseline and remained there for at least 30 minutes. Bars represent mean ± SD.
Figure 2. Dietary liberalization defined by frequency of glucose spikes (n = 14). The total number of glucose spikes was significantly higher during the unblinded continuous glucose monitoring (CGM) period compared to the blinded period (P = .005), suggesting potential dietary liberalization when patients were aware of their glucose readings in real time. Each dot represents an individual participant. A glucose spike was defined as an increase in CGM glucose of ≥40 mg/dL above baseline within 1 hour, which resolved when glucose returned to baseline and remained there for at least 30 minutes. Bars represent mean ± SD.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Reddy, 2000, Endotext
  2. Frier, 2009, The incidence and impact of hypoglycemia in type 1 and type 2 diabetes, Int Diabetes Monit, 21, 210

Cited by

See all 7

Metadata

Authors
Turk, N., Ramanujan, S., Shamloo, T., Craig, C., & McLaughlin, T.
Affiliations
Stanford Medicine (US)
Corresponding author
McLaughlin, Tracey
Venue
Journal of the Endocrine Society
Published
2025-06-18
Volume
9
Issue
9
Pages
bvaf106-bvaf106
ISSN
2472-1972 (ISSN-L)
OpenAlex
W4411713208
Cited by
7
References
20
Citations by year
2026: 4 · 2025: 3
FWCI
6.59
Type
journal article
Language
en
Open access
Locations
  • Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
American Diabetes Association
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
continuous glucose monitoring, hypoglycemia, hypoglycemia unawareness, quality of life, bariatric surgery complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.